| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 6.48M | — |
| Operating expense | — | — |
| Net income | 14.49M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, LKFT returned -10.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -11.9% |
| 1 year | -10.0% |
| 5 years | -51.0% |
| 10 years | -47.0% |
| All-time high | $222.88 (Jan 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in LKFT would be worth today ›No. Lakefront Biotherapeutics NV has not paid a dividend in the past 12 months.
Lakefront Biotherapeutics NV stock trades on NASDAQ under the ticker symbol LKFT.
Lakefront Biotherapeutics NV is part of the Healthcare sector.
Lakefront Biotherapeutics NV has a market cap of 1.89B USD, based on the latest quote.
Lakefront Biotherapeutics NV is scheduled to report earnings on Nov 12, 2026.
